The purpose of the starting dose is tolerance building, not dramatic weight loss
Sikiric P, Hahm KB, Blagaic AB, et al
Retatrutide works as a triple receptor agonist, targeting three key hormonal pathways simultaneously: [1] [4] GLP-1 (glucagon-like peptide-1): Is thought to reduce appetite and slow gastric emptying GIP (glucose-dependent insulinotropic polypeptide): Is thought to enhance insulin secretion and may influence fat metabolism, though human evidence remains limited Glucagon receptor: Has been observed in early studies to increase energy expenditure and promote fat breakdown, though the clinical significance in humans is still being established This triple-action mechanism distinguishes retatrutide from currently approved dual or single agonists
Choose whatever timing fits your routine best
They appear together on clinic menus, in wellness stacks, on podcasts
Results: Eight stroke survivors (4 female, 4 male) and 4 female PTs participated in the study